Abstract:BACKGROUND O-6-methylguanine-DNA methyltransferase (MGMT) is a suicide enzyme that repairs the mispairing base O-6-methyl-guanine induced by environmental and experimental carcinogens. It can transfer the alkyl group to a cysteine residue in its active site and became inactive. The chemical carcinogen N-nitroso compounds (NOCs) can directly bind to the DNA and induce the O-6-methylguanine adducts, which is an important cause of gene mutation and tumorigenesis. However, the underlying regulatory mechanism of MGMT involved in NOCs-induced tumorigenesis, especially in the initiation phase, remains largely unclear. AIM To investigate the molecular regulatory mechanism of MGMT in NOCs-induced gastric cell malignant transformation and tumorigenesis. METHODS We established a gastric epithelial cell malignant transformation model induced by N-methyl-N'-nitro-N-nitrosoguanidine (MNNG) or N-methyl-N-nitroso-urea (MNU) treatment. Cell proliferation, colony formation, soft agar, cell migration, and xenograft assays were used to verify the malignant phenotype. By using quantitative real-time polymerase chain reaction (qPCR) and Western blot analysis, we detected the MGMT expression in malignant transformed cells. We also confirmed the MGMT expression in early stage gastric tumor tissues by qPCR and immunohistochemistry. MGMT gene promoter DNA methylation level was analyzed by methylation-specific PCR and bisulfite sequencing PCR. The role of MGMT in cell malignant transformation was analyzed by colony formation and soft agar assays. RESULTS We observed a constant increase in MGMT mRNA and protein expression in gastric epithelial cell malignant transformation induced by MNNG or MNU treatment. Moreover, we found a reduction of MGMT gene promoter methylation level by methylation-specific PCR and bisulfite sequencing PCR in MNNG/MNU-treated cells. Inhibition of the MGMT expression by O-6-benzylguanine promoted the MNNG/MNU-induced malignant phenotypes. Overexpression of MGMT partially reversed the cell malignant transformation process induced by MNNG/MNU. Clinical gastric tissue analysis showed that MGMT was upregulated in the precancerous lesions and metaplasia tissues, but downregulated in the gastric cancer tissues. CONCLUSION Our finding indicated that MGMT upregulation is induced via its DNA promoter hypomethylation. The highly expressed MGMT prevents the NOCs-induced cell malignant transformation and tumorigenesis, which suggests a potential novel approach for chemical carcinogenesis intervention by regulating aberrant epigenetic mechanisms.

Cytotoxical Effect Of N-Methyl-N'-Nitro-N-Nitrosoguanimne On Mgmt Deficient Esophageal Epithelial Cells Was Related To The Induced Expression Of Hmsh2

Proteomic Profiling for Cellular Responses to Different Concentrations of N-Methyl-N '-Nitro-n-nitrosoguanidine

Proteomic Analysis of Different Temporal Expression Patterns Induced by N-Methyl-N′-nitro-N-nitrosoguanidine Treatment

O6-methylguanine DNA Methyltransferase is Upregulated in Malignant Transformation of Gastric Epithelial Cells Via Its Gene Promoter DNA Hypomethylation

Differential Nuclear Proteomes in Response to N-Methyl-N '-Nitro-n-nitrosoguanidine Exposure

Proteomic Analysis of Cellular Responses to Low Concentration N‐methyl‐N′‐nitro‐N‐nitrosoguanidine in Human Amnion FL Cells

Altered Expression of Zinc Finger Proteins, ADAMs, and Integrin‐related Proteins Following Treatment of Cultured Human Cells with a Low Concentration of N‐methyl‐N′‐nitro‐N‐nitrosoguanidine

Differential protein expression induced by low-concentration N-methyl-N′-nitro-N-nitrosoguanidine in FL cells using two-dimensional gel electrophoresis

Dutp Pyrophosphatase, Its Appearance in Extracellular Compartment May Serve As a Potential Biomarker for N-methyl-N'-nitro-N-nitrosoguanidine Exposure in Mammalian Cells.

Tp53 Mutation Form In Esophageal Cancer Cell Lines And Their Effect On Linduced Expression Of Mgmt And Mmr System

ATR–CHK1–E2F3 Signaling Transactivates Human Ribonucleotide Reductase Small Subunit M2 for DNA Repair Induced by the Chemical Carcinogen MNNG

Malignant Progression in O6-methylguanine-DNA Methyltransferase-Deficient Esophageal Cancer Cells is Associated with Ezrin Protein.

Study on cellular gene response to low concentration of MNNG in human amnion FL cells by high throughput real-time fluorescent PCR

[Activation of Proto-Oncogenes Induced by MNNG on Primary Culture of Human Gastric Epithelium and Immortalized Human Gastric Epithelial Cell Line].

N-methyl-N'-nitro- N-nitrosoguanidine Induces the Phosphorylation of Histone H2AX in CHL Cells

Identification of early responsive genes in human amnion epithelial FL cells induced by N-methyl-N'-nitro-N-nitrosoguanidine using oligonucleotide microarray and quantitative real-time RT-PCR approaches.

The Effects of N-methyl-N′-nitro-N-nitrosoguanidine on Cell Cycle Progression in Human Bronchial Epithelial(16hbe) Cells

Dose response to methylating agents in the γH2AX, SCE and colony formation assays: Effect of MGMT and MPG overexpression

The protective effect on eukaryotic cells transferred with MGMT gene

Protective Effect of O-6-Methylguanine-Dna-Methyltransferase on Mammalian Cells

Amino acid substitution polymorphisms of the DNA repair gene MGMT and the susceptibility to cervical carcinoma.